White, Helen E.
Salmon, Matthew
Albano, Francesco http://orcid.org/0000-0001-7926-6052
Andersen, Christina Søs Auður
Balabanov, Stefan
Balatzenko, Gueorgui
Barbany, Gisela
Cayuela, Jean-Michel
Cerveira, Nuno
Cochaux, Pascale
Colomer, Dolors http://orcid.org/0000-0001-7486-8484
Coriu, Daniel
Diamond, Joana http://orcid.org/0000-0002-7971-5900
Dietz, Christian
Dulucq, Stéphanie http://orcid.org/0000-0003-2728-7243
Engvall, Marie
Franke, Georg N.
Gineikiene-Valentine, Egle
Gniot, Michal http://orcid.org/0000-0002-7535-3316
Gómez-Casares, María Teresa
Gottardi, Enrico
Hayden, Chloe
Hayette, Sandrine
Hedblom, Andreas
Ilea, Anca
Izzo, Barbara http://orcid.org/0000-0002-7021-0367
Jiménez-Velasco, Antonio
Jurcek, Tomas
Kairisto, Veli
Langabeer, Stephen E.
Lion, Thomas
Meggyesi, Nora
Mešanović, Semir
Mihok, Luboslav
Mitterbauer-Hohendanner, Gerlinde
Moeckel, Sylvia
Naumann, Nicole
Nibourel, Olivier
Oppliger Leibundgut, Elisabeth
Panayiotidis, Panayiotis
Podgornik, Helena
Pott, Christiane
Rapado, Inmaculada
Rose, Susan J.
Schäfer, Vivien
Touloumenidou, Tasoula
Veigaard, Christopher
Venniker-Punt, Bianca
Venturi, Claudia
Vigneri, Paolo
Vorkinn, Ingvild
Wilkinson, Elizabeth
Zadro, Renata
Zawada, Magdalena
Zizkova, Hana
Müller, Martin C.
Saussele, Susanne http://orcid.org/0000-0003-0357-5785
Ernst, Thomas http://orcid.org/0000-0003-2147-489X
Machova Polakova, Katerina http://orcid.org/0000-0002-7398-5555
Hochhaus, Andreas http://orcid.org/0000-0003-0626-0834
Cross, Nicholas C. P. http://orcid.org/0000-0001-5481-2555
Funding for this research was provided by:
EUTOS
Article History
Received: 5 March 2022
Revised: 6 May 2022
Accepted: 12 May 2022
First Online: 25 May 2022
Competing interests
: HW has received honoraria from Novartis. SS has received honoraria from Incyte, Novartis, Pfizer, Bristol Myers Squibb, and Roche and research support from Incyte, Novartis, and Bristol Myers Squibb. J-MC has received research support and honoraria from Incyte, and honoraria from Novartis and Cepheid. TL has received honoraria from Incyte, Novartis, Pfizer, Angelini, Bristol Myers Squibb, and research support from Incyte, Novartis, and Pfizer. PV has received honoraria from Astra-Zeneca, Eli Lilly, Gilead; GlaxoSmithKline, Novartis, Pfizer, Roche, Teva, and research support from Novartis and Pfizer. SM is employed by the MLL Munich Leukemia Laboratory GmbH, Munich. CD and MM are employed by the Institute for Hematology and Oncology (IHO GmbH), Mannheim. KMP has received honoraria from Angelini and Incyte. AH received research support from Novartis, BMS, Pfizer, and Incyte. NC has received research support and honoraria from Novartis, and honoraria from Incyte and Astellas.